NCT01665183View on ClinicalTrials.gov

Ph 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma

PHASE1CompletedINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

Cutaneous Melanoma, Uveal Melanoma, Ovarian Carcinoma or Other Advanced Solid Tumors

Interventions

DRUG

ADI-PEG 20

Trial Locations (2)

704

NCKUH, Tainan City

Unknown

MD Anderson Cancer Center, Houston

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Polaris Group

INDUSTRY